Mironova M I, Lyskovtsev V V, Kaverina N V
Farmakol Toksikol. 1990 May-Jun;53(3):65-7.
The brief data on the results of the clinical trials of a new antiarrhythmic drug bonnecor at intravenous administration performed in six clinical institutions of the country are presented. A high effectiveness and a good tolerance of the drug in VT, VE, ST, SE and WPW syndrome were revealed.